Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
I would treat this as a credible, urgent safety signal, not as a finding that can wait six months for a completed regulatory submission. The estimate—liver failure in roughly 1 in 8,000 patients over five years—needs validation, but the outcome is severe and the current warning omits it.Read the full answer
Crisis Response Plan: 48 Hours to Board Meeting Foundational Principle Before laying out the timeline, let me anchor this in what I believe is the only defensible position: patient safety is non-negotiable. Here's why this isn't just ethics—it's also strategy.Read the full answer